978
Y. Oonishi et al.
PAPER
(E)-[5-4,4-Bis(benzyloxymethyl)-2-methylcyclopent-1-enyl-
Anal. Calcd for C26H32O2: C, 82.94; H, 8.57. Found: C, 82.99; H,
8.69.
pent-4-enyloxy]-tert-butyldimethylsilane (4g)
IR (neat): 2927, 2854, 1100 cm–1.
(E)-6-[4,4-Bis(benzyloxymethyl)-2-methylcyclopent-1-
enyl]hex-5-enal (4a)
1H NMR (400 MHz, CDCl3): d = 0.01 (s, 6 H), 0.86 (s, 9 H), 1.57
(tt, J = 7.1, 7.1 Hz, 2 H), 1.65 (s, 3 H), 2.11 (dt, J = 7.1, 7.1 Hz, 2
H), 2.24 (s, 2 H), 2.30 (s, 2 H), 3.39 (s, 4 H), 3.57 (t, J = 7.1 Hz, 2
H), 4.46 (s, 4 H), 5.43 (dt, J = 15.6, 7.1 Hz, 1 H), 6.24 (d, J = 15.6
Hz, 1 H), 7.19–7.30 (m, 10 H).
13C NMR (100 MHz, CDCl3): d = –5.0, 14.1, 18.6, 26.2, 29.6, 32.9,
40.0, 44.7, 45.7, 62.6, 73.2, 74.1, 124.6, 127.1, 127.2, 128.0, 129.3,
131.3, 133.2, 138.7.
IR (neat): 3028, 2850, 1724, 1454, 1100, 736, 698 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.69 (s, 3 H), 1.73 (tt, J = 7.3, 7.3
Hz, 2 H), 2.15 (dt, J = 7.3, 7.3 Hz, 2 H), 2.29 (s, 2 H), 2.33 (s, 2 H),
2.42 (td, J = 7.3, 1.4 Hz, 2 H), 3.43 (s, 4 H), 4.52 (s, 4 H), 5.40 (dt,
J = 15.5, 7.3 Hz, 1 H), 6.27 (d, J = 15.5 Hz, 1 H), 7.25–7.34 (m, 10
H), 9.76 (t, J = 1.4 Hz, 1 H).
13C NMR (67.8 MHz, CDCl3): d = 14.0, 22.0, 32.4, 39.8, 43.2, 44.7,
45.6, 73.2, 74.1, 125.6, 127.3, 127.3, 128.2, 128.3, 131.3, 134.1,
138.8, 202.5.
LRMS (EI): m/z = 520 [M+], 505, 429, 412, 355, 321, 249, 181, 91.
HRMS (EI): m/z calcd for C33H48O3Si: 520.3373; found: 520.3374.
LRMS (EI): m/z = 400 [M+ – H2O], 310, 279, 105, 91.
(E)-4,4-Bis(benzyloxymethyl)-1-methyl-2-pent-1-enylcyclopen-
tene (4h)
Anal. Calcd for C28H34O3: C, 80.35; H, 8.19. Found: C, 80.24; H,
8.23.
IR (neat): 2923, 2852, 1452, 1100, 734, 697 cm–1.
1H NMR (400 MHz, CDCl3): d = 0.90 (t, J = 7.5 Hz, 3 H), 1.40 (tq,
J = 7.5, 7.5 Hz, 2 H), 1.69 (s, 3 H), 2.09 (dt, J = 7.5, 7.5 Hz, 2 H),
2.28 (s, 2 H), 2.35 (s, 2 H), 3.43 (s, 4 H), 4.52 (s, 4 H), 5.47 (dt,
J = 15.4, 7.5 Hz, 1 H), 6.26 (d, J = 15.4 Hz, 1 H), 7.24–7.31 (m, 10
H).
13C NMR (100 MHz, CDCl3): d = 14.0, 14.1, 23.1, 34.5, 40.0, 44.7,
45.7, 73.2, 74.2, 124.4, 127.1, 127.2, 128.0, 129.9, 131.4, 133.0,
138.7.
(E)-1,1-Bis(benzyloxymethyl)-3-(but-2-enyl)-4-methylenecyclo-
pentane (4d¢)
IR (neat): 2923, 2856, 1116, 1100 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.16–1.25 (m, 1 H), 1.64 (d,
J = 5.1 Hz, 3 H), 1.87–1.95 (m, 2 H), 2.26–2.39 (m, 3 H), 2.42–2.51
(m, 1 H), 3.31–3.43 (m, 4 H), 4.52 (s, 4 H), 4.77 (s, 1 H), 4.84 (s, 1
H), 5.38 (dt, J = 15.3, 5.2 Hz, 1 H), 5.44 (dq, J = 15.3, 5.1 Hz, 1 H),
7.24–7.34 (m, 10 H).
13C NMR (100 MHz, CDCl3): d = 17.9, 37.6, 37.8, 40.2, 41.8, 45.8,
72.8, 73.2, 74.7, 105.2, 125.9, 127.3, 127.4, 128.2, 129.7, 138.9,
154.9.
LRMS (EI): m/z = 390 [M+], 299, 282, 191, 176, 161, 149, 131, 91.
HRMS (EI): m/z calcd for C27H34O2: 390.2559, found: 390.2558.
2,2-Bis(benzyloxymethyl)-5-methyl-cis-2,3,3a,4,5,7a-hexahy-
dro-1H-indene (5d)
LRMS (EI): m/z = 376 [M+ – Bn], 268, 207, 177, 147, 105, 91.
Anal. Calcd for C26H32O2: C, 82.94; H, 8.57. Found: C, 82.95; H,
8.63.
IR (neat): 2924, 2854, 2453, 1362, 1098, 733, 696 cm–1.
1H NMR (400 MHz, CDCl3): d = 0.92–0.95 (m, 1 H), 0.93 (d,
J = 7.0 Hz, 3 H), 1.20–1.32 (m, 2 H), 1.50–1.55 (m, 1 H), 1.79–1.90
(m, 2 H), 2.09–2.10 (m, 2 H), 2.41–2.43 (m, 1 H), 3.35–3.46 (m, 4
H), 4.51 (s, 4 H), 5.46 (d, J = 10.1 Hz, 1 H), 5.67 (ddd, J = 10.1,
3.3, 3.3 Hz, 1 H), 7.24–7.30 (m, 10 H).
13C NMR (100 MHz, CDCl3): d = 21.9, 31.1, 37.1, 37.3, 38.7, 38.9,
39.2, 47.6, 73.1, 74.1, 76.1, 127.0, 127.1, 128.0, 128.8, 133.1,
138.7.
(E)-4,4-Bis(benzyloxymethyl)-1-methyl-2-(propen-1-yl)cyclo-
pentene (4e)
IR (neat): 2911, 2850, 1452, 1361, 1100 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.69 (s, 3 H), 1.78 (d, J = 6.8 Hz,
3 H), 2.27 (s, 2 H), 2.34 (s, 2 H), 3.43 (s, 4 H), 4.52 (s, 4 H), 5.48
(dq, J = 15.3, 6.8 Hz, 1 H), 6.28 (d, J = 15.3 Hz, 1 H), 7.23–7.33 (m,
10 H).
13C NMR (100 MHz, CDCl3): d = 14.1, 18.8, 40.0, 44.8, 45.7, 73.2,
74.2, 124.4, 125.7, 127.1, 127.2, 128.1, 131.4, 132.8, 138.7.
LRMS (EI): m/z = 376 [M+], 285, 267, 267, 177, 159, 147, 131, 91.
Anal. Calcd for C26H32O2: C, 82.94; H, 8.57. Found: C, 82.89; H,
8.53.
LRMS (EI): m/z = 362 [M+], 271, 254, 165, 148, 133, 91.
Anal. Calcd for C25H30O2: C, 82.83; H, 8.34. Found: C, 82.64; H,
8.52.
2,2-Bis(benzyloxymethyl)-5-methyl-2,3,4,5,6,7-hexahydro-1H-
indene (5d¢)
IR (neat): 2920, 2846, 1453, 1361, 1099, 734, 697 cm–1.
(E)-4,4-Bis(benzyloxymethyl)-1-(but-1-enyl)-2-ethylcyclopen-
tene (4f)
1H NMR (400 MHz, CDCl3): d = 0.94 (d, J = 6.5 Hz, 3 H), 1.16–
1.25 (m, 1 H), 1.43–1.54 (m, 1 H), 1.63–1.68 (m, 2 H), 1.90–1.94
(m, 3 H), 2.06–2.17 (m, 4 H), 3.42 (s, 2 H), 3.43 (s, 2 H), 4.52 (s, 4
H), 7.23–7.34 (m, 10 H).
13C NMR (100 MHz, CDCl3): d = 21.8, 25.6, 29.2, 31.4, 34.3, 42.6,
42.8, 45.9, 73.2, 74.4, 127.2, 127.4, 128.2, 131.9, 132.0, 139.1.
IR (neat): 2922, 2850, 1453, 1362, 1101 cm–1.
1H NMR (400 MHz, CDCl3): d = 0.96 (t, J = 7.4 Hz, 3 H), 1.01 (t,
J = 7.5 Hz, 3 H), 2.08–2.18 (m, 4 H), 2.31 (s, 2 H), 2.36 (s, 2 H),
3.44 (s, 4 H), 4.52 (s, 2 H), 4.53 (s, 2 H), 5.52 (dt, J = 15.6, 6.8 Hz,
1 H), 6.27 (d, J = 15.6 Hz, 1 H), 7.26–7.37 (m, 10 H).
13C NMR (100 MHz, CDCl3): d = 13.0, 14.2, 21.5, 26.4, 40.1, 42.7,
44.6, 73.2, 74.1, 123.1, 127.1, 127.2, 128.0, 130.5, 131.6, 138.7,
138.9.
LRMS (EI): m/z = 376 [M+], 268, 177, 162, 147, 91.
HRMS (EI): m/z calcd for C26H32O2: 376.2402; found: 376.2399.
(E)-4,4-Bis(benzyloxymethyl)-1-(but-1-enyl)-2-methylcyclohex-
ene (26b)
LRMS (EI): m/z = 390 [M+], 298, 282, 191, 161, 131, 91.
Anal. Calcd for C27H34O2: C, 83.03; H, 8.77. Found: C, 82.97; H,
9.06.
IR (neat): 2921, 2852, 1453, 1099, 734, 697 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.02 (t, J = 7.3 Hz, 3 H), 1.60 (dd,
J = 6.5, 6.5 Hz, 2 H), 1.73 (s, 3 H), 1.99 (s, 2 H), 2.11–2.17 (m, 4
H), 3.34 (d, J = 8.8 Hz, 2 H), 3.40 (d, J = 8.8 Hz, 2 H), 4.48 (s, 4
Synthesis 2009, No. 6, 969–979 © Thieme Stuttgart · New York